Recent posts

I Resolve to Get Better mAb Separations

By August 8, 2018

We listened and learned how scientists separate mAbs and ADCs; then we designed a novel column for LC-MS bioseparations A critical step toward the prolific and successful use of monoclonal antibodies (mAb) as biotherapeutics occurred… Read more >

Categories: Columns
Tags: , , , , , , , ,

Setting a New Standard for Reserved-Phase Separations of Monoclonal Antibodies and Antibody Drug Conjugates

By May 15, 2018

A new approach to stationary phase chemistry for reversed-phase LC analysis of proteins, including monoclonal antibodies and antibody drug conjugates, delivers higher fidelity data especially for MS-based peak identification.

Categories: Columns
Tags: , , , , , , , , ,

A View of the Biopharmaceutical Industry in Asia — an Interview with Ken Fountain

By March 14, 2016

Ken Fountain, Director of Biopharmaceutical Business Development at Waters, recently returned from an insightful trip to Asia where he visited Waters customers in South Korea and attended the China Biopharma Executive Summit in Shanghai, in… Read more >

Categories: Pharmaceutical
Tags: , , ,

The Excitement and Frustration of ADCs

By October 8, 2015

Bioanalysis of Antibody Drug Conjugates in the Spotlight Few, if any, of the joggers along Boston’s Charles River could have realized the anticipation contained within the Hyatt Cambridge on a recent September Sunday morning. In… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , ,

Have we bridged the gap between qual and quan using HRMS?

By March 2, 2015

Increasing Size, Complexity and Potency: The Bioanalytical Challenge of the Next Decade, was the theme for the 3-day APA India held in Mumbai, India from February 23-25, 2015. Close to 300 attendees gathered to discuss… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , , , ,

Killing the cancer while keeping the patient healthy: ADCs

By November 19, 2014

One of the opportunities for personalized medicine is that by targeting a disease, can you eliminate the side effects of the cure? Antibody drug conjugates (ADCs) are one next-generation therapeutic approach that may have an… Read more >

Categories: Pharmaceutical
Tags: , ,